413 related articles for article (PubMed ID: 22262619)
1. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise.
Nguyen M; Ball R; Midthun K; Lieu TA
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():291-7. PubMed ID: 22262619
[TBL] [Abstract][Full Text] [Related]
2. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.
Baker MA; Nguyen M; Cole DV; Lee GM; Lieu TA
Vaccine; 2013 Dec; 31 Suppl 10():K98-112. PubMed ID: 24331080
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.
Yih WK; Lee GM; Lieu TA; Ball R; Kulldorff M; Rett M; Wahl PM; McMahill-Walraven CN; Platt R; Salmon DA
Am J Epidemiol; 2012 Jun; 175(11):1120-8. PubMed ID: 22582207
[TBL] [Abstract][Full Text] [Related]
4. Health outcomes of interest for evaluation in the Post-Licensure Rapid Immunization Safety Monitoring Program.
Lieu TA; Nguyen MD; Ball R; Martin DB
Vaccine; 2012 Apr; 30(18):2824-30. PubMed ID: 22394993
[TBL] [Abstract][Full Text] [Related]
5. Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza.
McCarthy NL; Gee J; Weintraub E; Donahue JG; Nordin JD; Daley MF; Naleway A; Henninger M; Baxter R; Crane B; Aukes L; Wagner N; Fisher S; Jacobsen SJ; Sy L; Baggs J
Vaccine; 2011 Jul; 29(31):4891-6. PubMed ID: 21596088
[TBL] [Abstract][Full Text] [Related]
6. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
7. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.
Platt R; Carnahan RM; Brown JS; Chrischilles E; Curtis LH; Hennessy S; Nelson JC; Racoosin JA; Robb M; Schneeweiss S; Toh S; Weiner MG
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():1-8. PubMed ID: 22262586
[TBL] [Abstract][Full Text] [Related]
8. Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.
Huang WT; Chen WW; Yang HW; Chen WC; Chao YN; Huang YW; Chuang JH; Kuo HS
Vaccine; 2010 Oct; 28(44):7161-6. PubMed ID: 20804804
[TBL] [Abstract][Full Text] [Related]
9. A vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program.
Baker MA; Lieu TA; Li L; Hua W; Qiang Y; Kawai AT; Fireman BH; Martin DB; Nguyen MD
Am J Epidemiol; 2015 Apr; 181(8):608-18. PubMed ID: 25769306
[TBL] [Abstract][Full Text] [Related]
10. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.
Salmon DA; Akhtar A; Mergler MJ; Vannice KS; Izurieta H; Ball R; Lee GM; Vellozzi C; Garman P; Cunningham F; Gellin B; Koh H; Lurie N;
Pediatrics; 2011 May; 127 Suppl 1():S78-86. PubMed ID: 21502251
[TBL] [Abstract][Full Text] [Related]
11. Manufacturers' postmarketing safety surveillance of influenza vaccine exposure in pregnancy.
Khromava A; Cohen CJ; Mazur M; Kanesa-thasan N; Crucitti A; Seifert H
Am J Obstet Gynecol; 2012 Sep; 207(3 Suppl):S52-6. PubMed ID: 22920060
[TBL] [Abstract][Full Text] [Related]
12. Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink.
Kharbanda EO; Vazquez-Benitez G; Shi WX; Lipkind H; Naleway A; Molitor B; Kuckler L; Olsen A; Nordin JD
Am J Obstet Gynecol; 2012 Sep; 207(3 Suppl):S47-51. PubMed ID: 22920059
[TBL] [Abstract][Full Text] [Related]
13. Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: a survey of health plans.
Moore KM; Duddy A; Braun MM; Platt R; Brown JS
Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1137-41. PubMed ID: 18763248
[TBL] [Abstract][Full Text] [Related]
14. Design considerations, architecture, and use of the Mini-Sentinel distributed data system.
Curtis LH; Weiner MG; Boudreau DM; Cooper WO; Daniel GW; Nair VP; Raebel MA; Beaulieu NU; Rosofsky R; Woodworth TS; Brown JS
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():23-31. PubMed ID: 22262590
[TBL] [Abstract][Full Text] [Related]
15. Preface to supplement. Active surveillance of vaccine safety in the US Food and Drug Administration's Mini-Sentinel program: identification of exposures and outcomes.
Vaccine; 2013 Dec; 31 Suppl 10():K1. PubMed ID: 24331068
[No Abstract] [Full Text] [Related]
16. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
17. Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance.
Salmon D; Yih WK; Lee G; Rosofsky R; Brown J; Vannice K; Tokars J; Roddy J; Ball R; Gellin B; Lurie N; Koh H; Platt R; Lieu T;
Health Aff (Millwood); 2012 Nov; 31(11):2518-27. PubMed ID: 23129683
[TBL] [Abstract][Full Text] [Related]
18. The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program.
Forrow S; Campion DM; Herrinton LJ; Nair VP; Robb MA; Wilson M; Platt R
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():12-7. PubMed ID: 22262588
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
[TBL] [Abstract][Full Text] [Related]
20. The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety.
Robb MA; Racoosin JA; Sherman RE; Gross TP; Ball R; Reichman ME; Midthun K; Woodcock J
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():9-11. PubMed ID: 22262587
[No Abstract] [Full Text] [Related]
[Next] [New Search]
